Muscular Dystrophy, Emery-Dreifuss
|
0.540 |
AlteredExpression
|
disease |
BEFREE |
To test this, we analyzed RNA-Seq datasets, finding novel isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dystrophy linked emerin gene.
|
29912636 |
2018 |
Muscular Dystrophy, Emery-Dreifuss
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
The more common X-linked recessive form of EDMD is caused by mutations in either EMD (encoding emerin) or FHL1 (encoding four and a half LIM domains 1), while mutations in LMNA (encoding lamin A/C), SYNE1 (encoding nesprin-1) and SYNE2 (encoding nesprin-2) lead to autosomal dominant forms of the condition.
|
23456229 |
2013 |
Muscular Dystrophy, Emery-Dreifuss
|
0.540 |
Biomarker
|
disease |
BEFREE |
Screening for DNA variations in the genes encoding nesprin-1 (SYNE1) and nesprin-2 (SYNE2) in 190 probands with EDMD or EDMD-like phenotypes identified four heterozygous missense mutations.
|
17761684 |
2007 |
Muscular Dystrophy, Emery-Dreifuss
|
0.540 |
Biomarker
|
disease |
BEFREE |
Fibroblasts obtained from EDMD5 (Emery Dreifuss muscular dystrophy) patients showed loss of Nesprin-2 from the nuclear envelope, corresponding reduced nuclear localization of BRCA1 and enhanced cytoplasmic Ca(2+).
|
26645154 |
2015 |
Atrial Fibrillation
|
0.420 |
AlteredExpression
|
disease |
BEFREE |
The analyses in peripheral blood showed association between AF risk SNPs and decreased expression of KCNN3 (0.85-fold; p=2.1×10(-4)); and increased expression of SYNE2 (1.12-fold; p=7.5×10(-24)); however, these associations were not detectable in atrial tissue.
|
26073630 |
2015 |
Atrial Fibrillation
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide association studies (GWAS) have identified common variants in nine genomic regions associated with AF (KCNN3, PRRX1, PITX2, WNT8A, CAV1, C9orf3, SYNE2, HCN4 and ZFHX3 genes); however, the genetic variability of these risk variants does not explain the entire genetic susceptibility to AF.
|
25391453 |
2015 |
Cardiomyopathies
|
0.120 |
Biomarker
|
group |
BEFREE |
Loss of the largest isoform Nesprin-2 Giant in mice is associated with a skin phenotype and altered wound healing, loss of C-terminal isoforms in mice leads to cardiomyopathies and neurological defects.
|
30220251 |
2018 |
Cardiomyopathies
|
0.120 |
GeneticVariation
|
group |
BEFREE |
To test this, we analyzed RNA-Seq datasets, finding novel isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dystrophy linked emerin gene.
|
29912636 |
2018 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
|
28390868 |
2017 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Additionally, immunohistochemistry showed higher levels of Nesprin-2 in many tumors in comparison with normal tissues.
|
24080406 |
2014 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Nesprin-2 was selected from two independent microarrays, based on its novelty in relation to cancer and its role in cell organization.
|
24080406 |
2014 |
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Variants in SYNE2, MRPL47 and BAHD1 genes are putative new risk factors for VIPN in childhood acute lymphoblastic leukemia.
|
30191766 |
2018 |
Leukemia, Myelocytic, Acute
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?
|
29025598 |
2017 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In a bivariate analysis combining the nevus results with a recent melanoma GWAS meta-analysis (12,874 cases, 23,203 controls), SNPs near GPRC5A, CYP1B1, PPARGC1B, HDAC4, FAM208B, DOCK8, and SYNE2 reached global significance, and other loci, including MIR146A and OBFC1, reached a suggestive level.
|
30429480 |
2018 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
SNORA23 increases expression of SYNE2, possibly through modulation of ribosome biogenesis, to promote PDAC cell survival and invasion, and growth and metastasis of xenograft tumors in mice.
|
28390868 |
2017 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Depleting fascin or specifically blocking the fascin-Nesprin-2 complex leads to defects in nuclear polarization, movement and cell invasion.
|
28060557 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Nesprin-2 was selected from two independent microarrays, based on its novelty in relation to cancer and its role in cell organization.
|
24080406 |
2014 |
Liver carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our findings indicate that variants of EGFR and SYNE2 play an important role in p21 regulation and are associated with the clinical outcome of HBV-related HCC in a TP53-indenpdent manner.
|
27502069 |
2016 |
EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Muscular Dystrophy, Emery-Dreifuss
|
0.540 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Atrial Fibrillation
|
0.420 |
Biomarker
|
disease |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
Atrial Fibrillation
|
0.420 |
Biomarker
|
disease |
CTD_human |
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
22544366 |
2012 |
Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |